.jpg)
Thomas Galloway, MD
Fox Chase Cancer Center
Disclosure:
Employment
Fox Chase Cancer Center: Attending Physician, Director of Clinical Research: Employee
Compensation
Varian: Speaker's Bureau
Leadership
Rare Tumors Task Force: Co-Chair
Head and Neck Cancer
Thomas Galloway, MD
Fox Chase Cancer Center
Matthew Katz, MD, FASTRO
Lowell General Hospital
This session will provide an overview of strengths/limitations of available studies and discuss ways to implement modern therapy in the era of HPV. The attendees will learn the current strategies for de-escalation and escalation in HPV-positive and HPV-negative oropharyngeal cancers. In addition, the session will provide evidence-based practices de-escalation or escalation strategies off protocol or on clinical trials. Finally, the practical ways to reconcile conflicting results from different studies will be addressed.
After moderators provide an overview, speakers will focus upon four topics:
- Treatment on and off protocol
- Treatment de-escalation strategies for HPV-positive tumors
- Treatment escalation with novel therapeutics for HPV-negative tumors
- Role of chemotherapy in early-stage disease treated with radiation
Fox Chase Cancer Center
Disclosure:
Employment
Fox Chase Cancer Center: Attending Physician, Director of Clinical Research: Employee
Compensation
Varian: Speaker's Bureau
Leadership
Rare Tumors Task Force: Co-Chair
Lowell General Hospital
Lunch Breakout Session: Private Practice Mentoring Session
Saturday, September 14
12:05 PM – 12:35 PM
Sunday, September 15
4:45 PM – 5:45 PM
Wednesday, September 18
1:15 PM – 1:20 PM
Wednesday, September 18
2:20 PM – 2:30 PM
The asset you are trying to access is locked. Please enter your access key to unlock.